 Monica Federico
Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 19 | 2024 | 1906 | 2.800 |
Why?
| | Social Determinants of Health | 5 | 2024 | 293 | 0.940 |
Why?
| | Anti-Asthmatic Agents | 2 | 2020 | 274 | 0.600 |
Why?
| | Virus Diseases | 1 | 2021 | 217 | 0.570 |
Why?
| | Medication Adherence | 2 | 2020 | 517 | 0.550 |
Why?
| | Patient Discharge | 1 | 2022 | 937 | 0.450 |
Why?
| | Health Status Disparities | 3 | 2024 | 313 | 0.410 |
Why?
| | School Health Services | 2 | 2024 | 226 | 0.340 |
Why?
| | Dexamethasone | 2 | 2019 | 371 | 0.310 |
Why?
| | Urban Population | 2 | 2024 | 481 | 0.290 |
Why?
| | Poverty | 3 | 2019 | 521 | 0.280 |
Why?
| | Child | 15 | 2024 | 22376 | 0.260 |
Why?
| | Healthcare Disparities | 2 | 2024 | 693 | 0.230 |
Why?
| | Anti-Ulcer Agents | 1 | 2005 | 14 | 0.220 |
Why?
| | Severity of Illness Index | 5 | 2024 | 2905 | 0.200 |
Why?
| | Health Services Accessibility | 4 | 2024 | 1066 | 0.200 |
Why?
| | Urban Health | 1 | 2003 | 95 | 0.190 |
Why?
| | Humans | 21 | 2024 | 142675 | 0.170 |
Why?
| | Needs Assessment | 1 | 2024 | 389 | 0.170 |
Why?
| | Prednisone | 2 | 2019 | 222 | 0.170 |
Why?
| | Lymphocyte Activation | 1 | 2005 | 1135 | 0.170 |
Why?
| | Phenotype | 2 | 2021 | 3160 | 0.160 |
Why?
| | Respiratory Sounds | 2 | 2021 | 106 | 0.160 |
Why?
| | Frustration | 1 | 2020 | 8 | 0.160 |
Why?
| | Aftercare | 1 | 2022 | 217 | 0.160 |
Why?
| | Societies, Medical | 1 | 2024 | 862 | 0.160 |
Why?
| | Residence Characteristics | 2 | 2020 | 376 | 0.160 |
Why?
| | Nebulizers and Vaporizers | 2 | 2017 | 67 | 0.150 |
Why?
| | Family Relations | 1 | 2020 | 90 | 0.150 |
Why?
| | Housing | 1 | 2020 | 145 | 0.150 |
Why?
| | Pneumonia | 1 | 2005 | 640 | 0.140 |
Why?
| | Environment | 2 | 2019 | 306 | 0.140 |
Why?
| | Allergens | 1 | 2021 | 390 | 0.140 |
Why?
| | Biomedical Research | 1 | 2024 | 705 | 0.140 |
Why?
| | Biomarkers | 2 | 2021 | 4227 | 0.130 |
Why?
| | Respiratory Tract Infections | 1 | 2021 | 393 | 0.130 |
Why?
| | Patient Education as Topic | 1 | 2022 | 783 | 0.120 |
Why?
| | Cholinergic Antagonists | 1 | 2016 | 23 | 0.120 |
Why?
| | T-Lymphocytes | 1 | 2005 | 2034 | 0.120 |
Why?
| | Positive-Pressure Respiration | 1 | 2017 | 111 | 0.120 |
Why?
| | Airway Remodeling | 1 | 2016 | 71 | 0.120 |
Why?
| | Hospitals, Pediatric | 1 | 2019 | 545 | 0.110 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1320 | 0.110 |
Why?
| | Albuterol | 2 | 2017 | 74 | 0.110 |
Why?
| | Glucocorticoids | 2 | 2017 | 539 | 0.110 |
Why?
| | Spirometry | 2 | 2024 | 264 | 0.110 |
Why?
| | Emergency Service, Hospital | 3 | 2022 | 2263 | 0.110 |
Why?
| | Bronchodilator Agents | 2 | 2017 | 194 | 0.110 |
Why?
| | Practice Guidelines as Topic | 2 | 2016 | 1521 | 0.110 |
Why?
| | Prevalence | 2 | 2016 | 2805 | 0.100 |
Why?
| | Risk Factors | 4 | 2019 | 10569 | 0.100 |
Why?
| | Drug Monitoring | 1 | 2016 | 393 | 0.090 |
Why?
| | Smoking | 1 | 2019 | 1552 | 0.090 |
Why?
| | United States | 3 | 2024 | 15496 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 1 | 2019 | 1319 | 0.080 |
Why?
| | Argyria | 1 | 2007 | 4 | 0.070 |
Why?
| | Adolescent | 6 | 2024 | 22135 | 0.070 |
Why?
| | Silver | 1 | 2007 | 37 | 0.070 |
Why?
| | Skin Pigmentation | 1 | 2007 | 48 | 0.070 |
Why?
| | Bronchial Provocation Tests | 1 | 2006 | 47 | 0.060 |
Why?
| | Colorado | 3 | 2024 | 4569 | 0.060 |
Why?
| | Bronchial Hyperreactivity | 1 | 2006 | 102 | 0.060 |
Why?
| | Patient-Centered Care | 1 | 2011 | 537 | 0.060 |
Why?
| | Histamine H2 Antagonists | 1 | 2005 | 23 | 0.060 |
Why?
| | Inhibitory Concentration 50 | 1 | 2005 | 91 | 0.060 |
Why?
| | Respiratory Hypersensitivity | 1 | 2005 | 68 | 0.050 |
Why?
| | Proton Pump Inhibitors | 1 | 2005 | 109 | 0.050 |
Why?
| | Male | 9 | 2024 | 71074 | 0.050 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2024 | 131 | 0.050 |
Why?
| | Forced Expiratory Volume | 1 | 2005 | 491 | 0.050 |
Why?
| | Reference Values | 1 | 2005 | 805 | 0.050 |
Why?
| | Interleukins | 1 | 2005 | 251 | 0.050 |
Why?
| | Vulnerable Populations | 1 | 2024 | 172 | 0.050 |
Why?
| | Female | 8 | 2024 | 76889 | 0.050 |
Why?
| | In Vitro Techniques | 1 | 2005 | 1049 | 0.050 |
Why?
| | Overweight | 1 | 2008 | 596 | 0.050 |
Why?
| | Community-Acquired Infections | 1 | 2005 | 176 | 0.050 |
Why?
| | Immune Tolerance | 1 | 2005 | 376 | 0.050 |
Why?
| | Delphi Technique | 1 | 2024 | 321 | 0.050 |
Why?
| | Child, Preschool | 3 | 2021 | 11599 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 2008 | 0.040 |
Why?
| | Hospitalization | 2 | 2021 | 2329 | 0.040 |
Why?
| | Gene Expression | 1 | 2005 | 1502 | 0.040 |
Why?
| | Pulmonologists | 1 | 2019 | 14 | 0.040 |
Why?
| | Symptom Flare Up | 1 | 2019 | 37 | 0.040 |
Why?
| | Drug Substitution | 1 | 2019 | 62 | 0.040 |
Why?
| | Environmental Exposure | 1 | 2003 | 583 | 0.040 |
Why?
| | Prospective Studies | 2 | 2024 | 7845 | 0.040 |
Why?
| | Pilot Projects | 1 | 2024 | 1830 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2003 | 639 | 0.030 |
Why?
| | Health Resources | 1 | 2019 | 128 | 0.030 |
Why?
| | Cystic Fibrosis | 1 | 2007 | 1114 | 0.030 |
Why?
| | Ipratropium | 1 | 2017 | 4 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 766 | 0.030 |
Why?
| | Consensus | 1 | 2019 | 479 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2005 | 2831 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2017 | 301 | 0.030 |
Why?
| | Disease Progression | 1 | 2024 | 2851 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2005 | 2395 | 0.030 |
Why?
| | Mass Screening | 1 | 2024 | 1317 | 0.030 |
Why?
| | Parents | 1 | 2024 | 1407 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 636 | 0.030 |
Why?
| | Hospitalists | 1 | 2019 | 265 | 0.030 |
Why?
| | Self Report | 1 | 2019 | 861 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1242 | 0.030 |
Why?
| | Age Factors | 1 | 2019 | 3266 | 0.020 |
Why?
| | Clinical Competence | 1 | 2019 | 1218 | 0.020 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2019 | 1389 | 0.020 |
Why?
| | Hospitals, Teaching | 1 | 2011 | 114 | 0.020 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2011 | 80 | 0.020 |
Why?
| | Drug Utilization | 1 | 2011 | 163 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 6315 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2021 | 16647 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 995 | 0.020 |
Why?
| | Colloids | 1 | 2007 | 61 | 0.020 |
Why?
| | Infant | 1 | 2021 | 9849 | 0.020 |
Why?
| | Complementary Therapies | 1 | 2007 | 90 | 0.020 |
Why?
| | Adult | 2 | 2008 | 39754 | 0.010 |
Why?
| | Aged | 1 | 2005 | 25297 | 0.010 |
Why?
| | Comorbidity | 1 | 2008 | 1632 | 0.010 |
Why?
| | Middle Aged | 1 | 2005 | 35224 | 0.010 |
Why?
| | Quality Improvement | 1 | 2011 | 1259 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2008 | 3601 | 0.010 |
Why?
| | Body Mass Index | 1 | 2008 | 2432 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2011 | 5952 | 0.010 |
Why?
|
|
Federico's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|